Endometrial hyperplasia, early diagnosis and therapy

Course Information
TitleΥπερπλασίες ενδομητρίου, πρώιμη διάγνωση-θεραπεία / Endometrial hyperplasia, early diagnosis and therapy
FacultyHealth Sciences
Cycle / Level2nd / Postgraduate
Teaching PeriodWinter
CoordinatorThemistoklis Dagklis
Course ID600021525

Programme of Study: PMS Prokarkinikés Pathīseis stī Gynaikología (2022-sīmera)

Registered students: 12
OrientationAttendance TypeSemesterYearECTS
KORMOSCompulsory Course116

Class Information
Academic Year2023 – 2024
Class PeriodWinter
Faculty Instructors
Instructors from Other Categories
Class ID
Course Type 2021
General Foundation
Mode of Delivery
  • Distance learning
Digital Course Content
Language of Instruction
  • Greek (Instruction, Examination)
General Competences
  • Apply knowledge in practice
  • Make decisions
  • Work autonomously
  • Work in an interdisciplinary team
  • Generate new research ideas
  • Advance free, creative and causative thinking
Educational Material Types
  • Video lectures
Use of Information and Communication Technologies
Use of ICT
  • Use of ICT in Course Teaching
  • Use of ICT in Communication with Students
  • Use of ICT in Student Assessment
Course Organization
Student Assessment
Student Assessment methods
  • Written Exam with Multiple Choice Questions (Formative, Summative)
Additional bibliography for study
1: Murakami I, Machida H, Morisada T, Terao Y, Tabata T, Mikami M, Hirashima Y, Kobayashi Y, Baba T, Nagase S. Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review. J Gynecol Oncol. 2023 Jul;34(4):e49. doi: 10.3802/jgo.2023.34.e49. Epub 2023 Mar 6. PMID: 36929578; PMCID: PMC10323306. 2: Elassall GM, Sayed EG, Abdallah NA, El-Zohiry MM, Radwan AA, AlMahdy AM, Sedik AS, Elazeem HASA, Shazly SA. Levonorgestrel-releasing intrauterine system versus systemic progestins in management of endometrial hyperplasia: A systemic review and meta-analysis. J Gynecol Obstet Hum Reprod. 2022 Oct;51(8):102432. doi: 10.1016/j.jogoh.2022.102432. Epub 2022 Jun 25. PMID: 35760334. 3: Petersdorf K, Groettrup-Wolfers E, Overton PM, Seitz C, Schulze-Rath R. Endometrial hyperplasia in pre-menopausal women: A systematic review of incidence, prevalence, and risk factors. Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:158-171. doi: 10.1016/j.ejogrb.2022.02.015. Epub 2022 Feb 17. PMID: 35217456. 4: Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022 Aug;306(2):407-421. doi: 10.1007/s00404-021-06380-5. Epub 2022 Jan 10. PMID: 35001185; PMCID: PMC9349105. 5: Mittermeier T, Farrant C, Wise MR. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Cochrane Database Syst Rev. 2020 Sep 6;9(9):CD012658. doi: 10.1002/14651858.CD012658.pub2. PMID: 32909630; PMCID: PMC8200645. 6: Tsakiridis I, Giouleka S, Koutsouki G, Kostakis N, Kalogiannidis I, Kourtis A, Athanasiadis A, Goulis DG, Dagklis T. Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations. Eur J Contracept Reprod Health Care. 2022 Dec;27(6):504-517. doi: 10.1080/13625187.2022.2112169. Epub 2022 Sep 2. PMID: 36053280.
Last Update